Badrilla has been awarded a Feasibility Study grant from the Technology Strategy Board to develop a range of novel, quantitative diagnostic assays based on the company’s patented quantification technology....
Read More
Badrilla Ltd, founded in 2003, is an established life science company providing high quality products for the molecular cardiovascular researcher located within major pharmaceutical, biotech, and academic establishments worldwide... Read More
Professor Colyer established Badrilla in 2003, combining substantive entrepeneurial experience with a deep understanding of the cardiovascular research field. The company has grown organically, reinvesting revenues into... Read More
Badrilla has been awarded a Feasibility Study grant from the Technology Strategy Board to develop a range of novel, quantitative diagnostic assays based on the company’s patented quantification technology....
Read More.
DISCLAIMER: Products for research use only (RUO) and are not intended for diagnostic or therapeutic use.